GSK shareholders approve asset swap deal with Novartis
December 18, 2014 at 08:11 AM EST
LONDON, Dec 18 (Reuters) - Shareholders in British drugmaker GlaxoSmithKline have approved a planned deal with Switzerland's Novartis, which will see the two pharmaceutical groups trade more than $20 billion of assets.
